Choosing breast cancer treatment may be difficult. Learn more about how doctors stage and treat breast cancer, plus more on breast cancer treatment options.
Menstrual irregularity means that something is wrong. Learn how to identify the signs and symptoms of an irregular period to prevent larger problems later
Diagnosing the causes of erectile dysfunction can help you take back control of your life. Learn which doctors to see for ED and which tests to expect here.
Acne treatments aim to stop current skin outbreaks, reduce skin problems in the future or treat acne scars. Learn which treatments doctors recommend here.
( ECCO-the European CanCer Organisation ) Results from a Phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome.
EAST HANOVER, N.J., Sept. 25, 2011 /PRNewswire/ -- A pivotal Phase III study shows Afinitor® (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and signif
( ECCO-the European CanCer Organisation ) New research has found that breast cancer tumors change their hormonal status throughout the course of disease, whereas the decision about the most effective treatment for the patient is usually only based on one
Afinitor (evelolimus), a Novartis kidney cancer drug, when combined with hormonal therapy doubled breast cancer patients' progression-free survival, and reduced cancer progression risk by 57% compared to exemestane alone, researchers revealed during a Pre
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57%